Scribd Logo
Upload

Welcome to Scribd!

  • Critique

    Uploaded by

    Katia
    9 views2 pages
    The article discusses two common screening tests - the PSA test for prostate cancer and prenatal genetic screening. It supports the view that the accuracy and emotional impact of screening tests should be considered before widespread public use. However, the critique notes some drawbacks of the article, including that it does not mention the financial costs or benefits of screening programs. It also observes that the references are mostly older and focused only on the PSA test, rather than other screenings where early detection can be beneficial.

    Original Description:

    PSA

    Copyright

    © © All Rights Reserved

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    The article discusses two common screening tests - the PSA test for prostate cancer and prenatal genetic screening. It supports the view that the accuracy and emotional impact of screening tests should be considered before widespread public use. However, the critique notes some drawbacks of the article, including that it does not mention the financial costs or benefits of screening programs. It also observes that the references are mostly older and focused only on the PSA test, rather than other screenings where early detection can be beneficial.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as docx, pdf, or txt
    9 views2 pages

    Critique

    Uploaded by

    Katia
    The article discusses two common screening tests - the PSA test for prostate cancer and prenatal genetic screening. It supports the view that the accuracy and emotional impact of screening tests should be considered before widespread public use. However, the critique notes some drawbacks of the article, including that it does not mention the financial costs or benefits of screening programs. It also observes that the references are mostly older and focused only on the PSA test, rather than other screenings where early detection can be beneficial.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as docx, pdf, or txt
    of 2

    Critique (Kat):

    The article provides great examples of two popular screening tests


    that are used very frequently: the PSA test and the pre natal genetic
    disorder-screening test. The examples support the myth busters view
    on the topic, which is to consider the accuracy of the test and
    emotional implications it may have on the patient, before it is used for
    screening the public. However, some drawbacks of the data
    presented is as follows:
    The article does not mention any associated costs or overall
    financial benefit to the healthcare system created by avoiding
    mandatory testing of the population. For example, the initial
    PSA test is not covered by OHIP (BC also does not cover the
    cost). The patient is to pat the $30 charge, and then if the
    screening test comes back positive, the cost is waived and
    future tests are of no cost to them. This structure may also raise
    questions regarding screening compliance in Ontario and
    British Columbia. According to a study conducted in BC, the
    incremental cost-effectiveness of regular screening ranged from
    $36,300/Life Year Gained, for screening every four years from
    ages 55 to 69 years, to $588,300/Life Year Gained, for
    screening every two years from ages 40 to 74 years.
    Majority of the articles referenced are focused on PSA tests and
    do not mention any others. There are several instances when
    early detection is very beneficial and the disease is curable
    when detected at an early stage.
    Sources of reference are not current. Most articles are dated
    ten years or older and during this time reliability of the
    technology used to test for prostate cancer and other diseases
    has increased, therefore decreasing the high number of false
    positive results.
    Parkinsons/Alzheimer
    Diabetes

    http://www.thestar.com/news/canada/2012/05/21/prostate_cancer_scr
    eening_test_costs_ontario_patients_30.html
    http://prostatecancer.ca/In-The-News/Foundation-NewsReleases/Prostate-Cancer-Canada-advocates-for-Ontario-topa#.U8bckJRdXpU
    30$
    http://onlinelibrary.wiley.com.libaccess.lib.mcmaster.ca/doi/10.1002/ijc
    .28732/abstract;jsessionid=A10321E9DFCB89BE148E4A61E13E5B
    28.f01t04

    You might also like